EUVIMEDEUVIMED entdecken
Crossref

Quantification of Pectolinarin in Rat Plasma Using UPLC‐MS/MS and Its Pharmacokinetic Analysis

Mengmeng Shao, Runrun Wang, Congcong Wen, Xianqin Wang, Yongxi Jin iD, Saiya Chen

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Mengmeng Shao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Chromones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pectolinarin is a flavonoid compound known for its wound‐healing properties, including anti‐inflammatory and antibacterial effects. In this study, we employed UPLC‐MS/MS to quantify pectolinarin in rat plasma and investigate its pharmacokinetics. Plasma samples were processed using an acetonitrile precipitation method. Chromatographic separation was performed on a UPLC BEH column with a gradient mobile phase of acetonitrile‐water (containing 0.1% formic acid). Detection was carried out using electrospray ionization (ESI) tandem mass spectrometry in multiple reaction monitoring (MRM) mode with positive ionization, targeting transitions of m / z 623.3 → 315.3 for pectolinarin and m / z 370.5 → 125.0 for the IS. The results demonstrated that pectolinarin exhibited acceptable linearity in rat plasma within the concentration range of 1.2 to 2300 ng/mL ( r > 0.995). The intraday and interday precision, expressed as relative standard deviation (RSD), was below 9.2%. Accuracy ranged from 97.3% to 108.3%, with average recovery exceeding 94.7%. The matrix effect was between 97.8% and 105.3%. The method was successfully applied to evaluate the pharmacokinetics of pectolinarin in rats following both oral and intravenous administration. The absolute bioavailability of pectolinarin in rats was determined to be 0.28%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryChromonesAnimalsRatsChromatography, High Pressure LiquidReproducibility of ResultsMaleRats, Sprague-DawleyLinear ModelsLimit of DetectionSensitivity and SpecificityDrug StabilityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

UPLC‐MS/MSbioavailabilitypectolinarinpharmacokineticsrat

Substanzen

pectolinarigeninChromones

Autor:innen und Institutionen

  • Department of Rehabilitation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Department of Rehabilitation Medicine, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Wenzhou, China.
  • Department of Geriatrics, Wenzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medicine University, Wenzhou, China.

ORCID-Profile: Yongxi Jin

Zitieren

APA

Shao, M., Wang, R., Wen, C., Wang, X., Jin, Y., & Chen, S. (2025). Quantification of Pectolinarin in Rat Plasma Using UPLC‐MS/MS and Its Pharmacokinetic Analysis. Biomedical Chromatography. https://doi.org/10.1002/bmc.70032

Vancouver

Shao M, Wang R, Wen C, Wang X, Jin Y, Chen S. Quantification of Pectolinarin in Rat Plasma Using UPLC‐MS/MS and Its Pharmacokinetic Analysis. Biomedical Chromatography. 2025. doi:10.1002/bmc.70032

BibTeX
@article{Shao2025,
  author = {Shao, Mengmeng and Wang, Runrun and Wen, Congcong and Wang, Xianqin and Jin, Yongxi and Chen, Saiya},
  title = {Quantification of Pectolinarin in Rat Plasma Using UPLC‐MS/MS and Its Pharmacokinetic Analysis},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70032}
}
Kostenlos starten →